3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Thrombocythemia, Essential
1
Recurrence
1
Primary Myelofibrosis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Interventions
Cyclophosphamide
7
fludarabine
6
Whole-Body Irradiation
6
Tacrolimus
6
Mycophenolic Acid
6
ruxolitinib
5
fludarabine phosphate
5
Melphalan
5
venetoclax
4
Peripheral Blood Stem Cell Transplantation
4
itacitinib
3
Specimen Handling
3
Sirolimus
3
Granulocyte Colony-Stimulating Factor
3
Cytarabine
3
Biopsy
3
Azacitidine
3
navitoclax
2
luspatercept
2
Etoposide
2
Daunorubicin
2
Busulfan
2
Antilymphocyte Serum
2
thymoglobulin
1
selinexor
1
quizartinib
1
pomalidomide
1
plerixafor
1
pevonedistat
1
parsaclisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Myeloproliferative Disorders
×
INCB057643
×
Clear all
NCT04279847
2026-04-01
LIMBER
Incyte Corporation
Phase 1
Active not recruiting
140 enrolled